Working…
COVID-19 is an emerging, rapidly evolving situation.
Get the latest public health information from CDC: https://www.coronavirus.gov.

Get the latest research information from NIH: https://www.nih.gov/coronavirus.
ClinicalTrials.gov
ClinicalTrials.gov Menu

Impact of Discontinuing Chronic Therapies in People With Cystic Fibrosis on Highly Effective CFTR Modulator Therapy (SIMPLIFY)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT04378153
Recruitment Status : Not yet recruiting
First Posted : May 7, 2020
Last Update Posted : May 8, 2020
Sponsor:
Collaborators:
Cystic Fibrosis Foundation
Dartmouth-Hitchcock Medical Center
University of Washington
Information provided by (Responsible Party):
David Nichols, MD, Seattle Children's Hospital

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Not yet recruiting
Estimated Primary Completion Date : May 31, 2022
Estimated Study Completion Date : May 31, 2022